Pretraživanje
Prikaz rezultata 1-10 od 235
Sex differences in the clinical presentation and therapy of multiple sclerosis / Polne razlike u kliničkoj slici i terapiji multiple skleroze
(Savez farmaceutskih udruženja Srbije, Beograd, 2016)
Multiple sclerosis (MS) is more prevalent in women than in men, with the female to male ratio in the prevalence of MS constantly increasing. Besides, sex appears to affect the development, progression, clinical manifestation ...
Novel pharmaceutical dosage forms of analgesics / Savremeni farmaceutski oblici analgetika
(Savez farmaceutskih udruženja Srbije, Beograd, 2019)
Among novel pharmaceutical dosage forms of analgesics, whose number and diversity are continuously increasing over the past two decades, of particular importance are transdermal opioid analgesics (fentanyl, buprenorphine) ...
3D-QSAR modeling and pharmacophore study of serotonin 5HT-₂A receptors antagonists / 3D-QSAR modelovanje i analiza farmakofore antagonista serotoninskih 5-HT2A receptora
(Savez farmaceutskih udruženja Srbije, Beograd, 2017)
Creation of a statistically reliable 3D-QSAR (Quantitative Structure Activity Relationships) model enables definition of the structure of the pharmacophore for antagonists of serotonin 5-HT2A receptors and selection of the ...
Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients / Matriks metaloproteinaze-9 i tkivni inhibitori matriks metaloproteinaza-1 kod pacijenata sa sarkoidozom
(Savez farmaceutskih udruženja Srbije, Beograd, 2017)
Matrix metaloproteinases (MMPs) and their specific inhibitors - tissue inhibitors of matrix metalloproteinases (TIMPs) play an important role in pulmonary extracellular matrix destruction. Sarcoidosis is an inflammatory ...
Investigation of omeprazole stability in oral suspensions for pediatric use prepared extemporaneously from omeprazole capsules / Ispitivanje stabilnosti oralnih suspenzija omeprazola za pedijatrijsku primenu magistralno izrađenih iz omeprazol kapsula
(Savez farmaceutskih udruženja Srbije, Beograd, 2017)
In this paper, a study exploring the stability of omeprazole in pediatric suspensions is presented. In order to determine the most suitable suspension, three different formulations were prepared and stored under refrigerated ...
Resistin, inflammation and dyslipidemia in obese children and adolescents / Rezistin, inflamacija i dislipidemija kod gojazne dece i adolescenata
(Savez farmaceutskih udruženja Srbije, Beograd, 2015)
Introduction: Childhood obesity is related to cardiovascular diseases and diabetes mellitus type 2 in later life. Resistin, an adipokine primarily secreted by monocytes and tissue macrophages in humans, is considered to ...
Novel approaches in the treatment of multiple sclerosis / Novine u terapiji multiple skleroze
(Savez farmaceutskih udruženja Srbije, Beograd, 2015)
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system, which usually affects young adults. The most common clinical course of the disease is the relapsing-remitting form of multiple sclerosis ...
Drug stability: Industry view / Stabilnost lekova - industrijski aspect
(Savez farmaceutskih udruženja Srbije, Beograd, 2011)
Stability testing is carried out in several phases of new product development. The effect of various external factors on possible formulations, compatibility of active pharmaceutical ingredient, excipients and primary ...
Lipophilicity determination of β-hydroxy-β-arilalkanoic acids by reversed phase liquid chromatography under high pressure / Određivanje lipofilnosti β-hidroksi-β-arilalkanskih kiselina primenom reverzno-fazne tečne hromatografije pod visokim pritiskom
(Savez farmaceutskih udruženja Srbije, Beograd, 2018)
Lipophilicity parameters (logP) were determined for thirteen synthesized β-hydroxy-β-arilalkanoic acids using reversed phase high performance liquid chromatography. Anti-inflammatory activity and potential selectivity ...
Safety of cosmetic products in the light of European legislation: Cosmetic Regulation (EC) No 1223/2009 / Bezbednost kozmetičkih proizvoda u svetlu evropskih propisa - kozmetička uredba 1223/2009
(Savez farmaceutskih udruženja Srbije, Beograd, 2018)
After several accidental situations in the cosmetics industry which led to fatal outcomes, the reappeared a need to regulate cosmetics manufacturing. On July 1976 Cosmetic Directive 76/768/EEC came into force with the aim ...